
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[ASND] Ascendis Pharma A/S - FCF / Share
Data updated 2023-Jun-24 (Saturday)Note: Detailed Statistics for FCF / Share in Cashflow Statement for Ascendis Pharma A/S [NASDAQ:ASND] with frequency distribution chart that analyze trends & history . FCF per share is a valuation metric calculated as Free Cash Flow / Shares Outstanding for period. View Cashflow Statement for broader context
Share
Quarterly FCF / Share values for Ascendis Pharma A/S are rounded to enhance readability
2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | 2021-Dec | |
---|---|---|---|---|---|---|
FCF / Share | -2.83 | -2.57 | -1.8 | -2.45 | -2.66 | -2.59 |
Sequential Quarter Growth | -10.1% | -42.8% | +26.5% | +7.9% | -2.7% | -9.7% |
Quarter-on Quarter Growth | -6.4% | +0.8% | +23.7% | +7.9% | -38.5% | -25.1% |
Annual FCF / Share values for Ascendis Pharma A/S are rounded to enhance readability
2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | 2017-Dec | |
---|---|---|---|---|---|---|
FCF / Share | -9.56 | -9.3 | -6.07 | -4 | -3.59 | -2.64 |
Year-on-Year Growth | -2.8% | -53.2% | -51.8% | -11.4% | -36.0% | -32.0% |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly FCF / Share values from 2016-Sep-30 grouped into buckets. Latest FCF / Share value is -2.83 as of 2023-Mar-31
Subsequent stock performance post earnings date till next announcement for Ascendis Pharma A/S mapped with quarterly FCF / Share values reported at that time. Most recent value denoted with star
Select frequency and calculation type for FCF / Share above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Ascendis Pharma A/S with subsequent post-earnings performance given FCF / Share values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
FCF / Share - Low | 63% | 38% |
FCF / Share - Medium | 50% | 50% |
FCF / Share - High | 38% | 63% |
FCF / Share (Sequential growth %) - Low | 63% | 38% |
FCF / Share (Sequential growth %) - Medium | 38% | 63% |
FCF / Share (Sequential growth %) - High | 57% | 43% |
FCF / Share (QoQ growth %) - Low | 86% | 14% |
FCF / Share (QoQ growth %) - Medium | 29% | 71% |
FCF / Share (QoQ growth %) - High | 50% | 50% |
Related to Ascendis Pharma A/S
Information for Ascendis Pharma A/S
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-19 on Google
SEC Reports : Quarterly reports around 2025-May-19 on SEC Edgar
Compare Ascendis Pharma A/S with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ascendis Pharma A/S
Industry : Pharmaceuticals industry performance which includes Ascendis Pharma A/S